您现在位置：健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Research Report on Chinese Proton Pump Inhibitors Market

健康网讯：

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  July 2006
Format:  Hardcopy and Adobe PDF
Price:  US$1,600
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68052505
E-mail: bianch@healthoo.com   wuhf@healthoo.com                     
http://www.healthoo.com

Tables of contents
Summary
First part：Categories of drugs and their definitions
1 Categories of stomach diseases and the epidemic trend
2 Overview of drugs for peptic ulcer
Second part：Sales statistic in sample hospitals
1 Market scale and growth trend of drugs for stomach diseases
2 Market scale and growth trend of drugs for peptic ulcer
  2.1 Market scale and growth trend from 2002 to 2006
  2.2 Market shares of different categories from 2002 to 2006
  2.3 Market shares of different products belonging to Proton Pump Inhibitors from 2002 to 2006
  2.4 Analysis on key products (Proton Pump Inhibitors) and enterprsies in 2006
     Omeprazole
     Esomeprazole
     Pantoprazol
     Lansoprazole
     Rabeprazole
Third part：Sales statistic of retail market for stomach diseases in 2006
1 Market shares of different categories for stomach diseases
2 Market shares of different brands in key cities
Forth part：Information of R&D
1 New drugs and trial drugs in the world
   Ilaprazole
   TAK-390MR
   Tenatoprazole
   Leminoprazole
   radpid　release formulation of Omeprazole
   Other
2 R&D in China
  2.1 List of Domestic marketd products and import procucts
  2.2 Status of application and approval
Appendix
Appendix 1: Reference retail prices of popular stomach drugs
Appendix 2: The products listed in Drug Catalogue of National Basic Medical Insurance
Appendix 3: Infromation of application and approval for stomach drugs